About
Activity
-
I’m pleased to share some exciting news from Oncology R&D, AstraZeneca. We have entered into a license and option agreement with Pinetree…
I’m pleased to share some exciting news from Oncology R&D, AstraZeneca. We have entered into a license and option agreement with Pinetree…
Liked by Sergio Martínez Cuesta
-
I’m delighted to share that AstraZeneca has entered into a license and option agreement with Pinetree Therapeutics, a biotechnology company…
I’m delighted to share that AstraZeneca has entered into a license and option agreement with Pinetree Therapeutics, a biotechnology company…
Liked by Sergio Martínez Cuesta
-
If you want to join our journey to discover new oncology medicines using computational methods - join Kathryn Giblin's team at AstraZeneca in…
If you want to join our journey to discover new oncology medicines using computational methods - join Kathryn Giblin's team at AstraZeneca in…
Shared by Sergio Martínez Cuesta
Experience
Education
Publications
-
DNA G-quadruplex structures mold the DNA methylome
Nature Structural & Molecular Biology
-
Sequencing 5‐Hydroxymethyluracil at Single‐Base Resolution
Angewandte Chemie International Edition
-
Exploring the chemistry and evolution of the isomerases
Proceedings of the National Academy of Sciences
-
The classification and evolution of enzyme function
Biophysical Journal
-
The evolution of enzyme function in the isomerases
Curr. Opin. Struct. Biol.
Languages
-
Spanish
Native or bilingual proficiency
-
English
Native or bilingual proficiency
-
French
Elementary proficiency
-
German
Elementary proficiency
-
Russian
Elementary proficiency
Organizations
-
Wolfson College
College Research Associate
- Present -
Biochemical Society
Member
- Present -
Gonville and Caius College
PhD student
-
More activity by Sergio
-
Wrapping up an intense, productive week with our partners AstraZeneca in Cambridge and London UK 🇬🇧 including meetings with DS&AI leadership team…
Wrapping up an intense, productive week with our partners AstraZeneca in Cambridge and London UK 🇬🇧 including meetings with DS&AI leadership team…
Liked by Sergio Martínez Cuesta
-
I am happy to announce the release of QSARtuna; our molecular property prediction tool for in silico protein target prediction, ADMET modelling…
I am happy to announce the release of QSARtuna; our molecular property prediction tool for in silico protein target prediction, ADMET modelling…
Liked by Sergio Martínez Cuesta
-
Dreaming of leading your own research group in computational biology and bioinformatics? We’re recruiting two ambitious research group leaders from…
Dreaming of leading your own research group in computational biology and bioinformatics? We’re recruiting two ambitious research group leaders from…
Liked by Sergio Martínez Cuesta
-
Congratulations to TenAces Biosciences Bioinformatics lead Chen Lior on culmination of her #PhD at the Weizmann Institute of Science !
Congratulations to TenAces Biosciences Bioinformatics lead Chen Lior on culmination of her #PhD at the Weizmann Institute of Science !
Liked by Sergio Martínez Cuesta
-
AION Labs #companycreation #workshop day 1: Team Building Day” at Amazon Web Services (AWS) headquarters in Tel Aviv Great aspiring…
AION Labs #companycreation #workshop day 1: Team Building Day” at Amazon Web Services (AWS) headquarters in Tel Aviv Great aspiring…
Liked by Sergio Martínez Cuesta
-
Still reflecting on one of the most intense and fulfilling weeks of my career... Last week, I had the incredible opportunity to participate in AION…
Still reflecting on one of the most intense and fulfilling weeks of my career... Last week, I had the incredible opportunity to participate in AION…
Liked by Sergio Martínez Cuesta
-
An exciting evening launching our new Israel 🇮🇱 #pharmatech founders forum together with amazing partners Startup Nation Central, Arkin Digital…
An exciting evening launching our new Israel 🇮🇱 #pharmatech founders forum together with amazing partners Startup Nation Central, Arkin Digital…
Liked by Sergio Martínez Cuesta
-
It has been an exciting week with progress of our antibody drug conjugate (ADC) pipeline shared at ASCO, and today marking the completion of our…
It has been an exciting week with progress of our antibody drug conjugate (ADC) pipeline shared at ASCO, and today marking the completion of our…
Liked by Sergio Martínez Cuesta
-
Wrapping up our first innovation workshop of 2024 at AION Labs! 16 incredibly talented scientists participated in our challenge to build an #AI…
Wrapping up our first innovation workshop of 2024 at AION Labs! 16 incredibly talented scientists participated in our challenge to build an #AI…
Liked by Sergio Martínez Cuesta
-
Kicking off our 7th AION Labs workshop in Jerusalem, like always We continue to build new tech.bio startups here in Israel 🇮🇱 #nomatterwhat…
Kicking off our 7th AION Labs workshop in Jerusalem, like always We continue to build new tech.bio startups here in Israel 🇮🇱 #nomatterwhat…
Liked by Sergio Martínez Cuesta
Other similar profiles
-
Russell Hamilton
Connect -
Stefan Schiesser
Connect -
Noora Kattouf
Deep Tech & Deep Science investor | AMITI Ventures
Connect -
Dylan Ramage
PhD Researcher at the University of Cambridge
Connect -
Philip Tedder
Connect -
Rafi Emmanuel, Ph.D.
Connect -
Lewis Mervin
Connect -
Claire Mayo
Connect -
Ingo Kober
Connect -
Hui Sun Leong
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Sergio Martínez Cuesta
-
Sergio Martinez Cuesta
-
Sergio Cuesta Martínez
-
Sergio Martínez Cuesta
--
-
Sergio martinez cuesta
Profesional de Ingeniería civil
6 others named Sergio Martínez Cuesta are on LinkedIn
See others named Sergio Martínez Cuesta